Sanara MedTech, Inc. (SMTI)
| Market Cap | 207.85M |
| Revenue (ttm) | 14.15M |
| Net Income (ttm) | -5.57M |
| Shares Out | 6.23M |
| EPS (ttm) | -1.06 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 5 |
| Last Price | $28.75 |
| Previous Close | $28.36 |
| Change ($) | 0.39 |
| Change (%) | 1.38% |
| Day's Open | 29.69 |
| Day's Range | 26.39 - 29.85 |
| Day's Volume | 47,748 |
| 52-Week Range | 26.39 - 53.85 |
News
These companies made millions by developing equipment for life-saving care, and enriched shareholders too.
FORT WORTH, TX / ACCESSWIRE / December 23, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (NASDAQ:SMTI), a provider of wound and skin ca...
About SMTI
Sanara MedTech develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical Activated Collagen Adjuvant powder that helps in the natural wound healing process; Biako¯s Antimicrobial Skin & Wound Cleanser, a patented wound cleansing spray that disrupts extracellular polymeric substances to eradicate biofilm; and Biako¯s Antimicrobial Skin & Wound Irrigation Solution that works to irrigate and remove microbes from the... [Read more...]
| Industry Medical Care Facilities | Founded 1982 |
| Stock Exchange NASDAQ | Ticker Symbol SMTI |
Financial Performance
In 2019, Sanara MedTech's revenue was $11.77 million, an increase of 101.56% compared to the previous year's $5.84 million. Losses were -$2.81 million, 368.6% more than in 2018.